Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis
Summary: Background/Objective: CD133 is currently considered the most robust surface marker for colorectal cancer stem cells. Two meta-analysis reports have suggested that CD133 expression is significantly associated with shorter survival, and CD133 may play an important role in the progression of...
Main Authors: | Shinsuke Kazama, Junko Kishikawa, Tomomichi Kiyomatsu, Kazushige Kawai, Hiroaki Nozawa, Soichiro Ishihara, Toshiaki Watanabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-05-01
|
Series: | Asian Journal of Surgery |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958416303359 |
Similar Items
-
Colorectal cancer with venous tumor thrombosis
by: Kensuke Otani, et al.
Published: (2018-05-01) -
Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis
by: Hideomi Yamashita, et al.
Published: (2017-09-01) -
Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Kazushige Kawai, et al.
Published: (2017-04-01) -
Smoking and tumor obstruction are risk factors for anastomotic leakage after laparoscopic anterior resection during rectal cancer treatment
by: Hiroyuki Matsuzaki, et al.
Published: (2017-01-01) -
Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report
by: Koji Yasuda, et al.
Published: (2017-08-01)